Community Acquired Pneumonia Guidelines
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
The effects of positive end expiratory pressure in COVID-19-related acute respiratory distress syndrome (ARDS) are similar to those reported in classical ARDS.
Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.
Pneumomediastinum, although a rare phenomenon, is more prevalent in patients with COVID-19 compared with historical patients with adult respiratory distress syndrome.
An interim analysis of the phase 2 study evaluated the combination therapy in recently diagnosed patients with mild to moderate COVID-19.
Patients with severe COVID-19 pneumonia had improved prognosis after receiving a short course of methyl-prednisolone pulses during the second week of disease.
The antibody solution is derived from plasma donated by healthy individuals who have recovered from COVID-19.
The second part of the study will assess the efficacy and safety of a single intravenous infusion of VIR-7831 in approximately 1300 patients.
Although hospitalization risk was higher, mortality, thrombosis, and ICU admission risks were the same in patients with and without liver transplants.
Remdesivir was immediately discontinued in both patients and a continuous infusion of acetylcysteine was initiated.